NeoGenesis Capital Debuts Fund Backing Colossal Biosciences Spinouts
NeoGenesis Capital has launched its debut fund targeting spinouts from Colossal Biosciences, betting on ventures emerging from the genetic engineering startup's research pipeline.
Topic
Topic
NeoGenesis Capital has launched its debut fund targeting spinouts from Colossal Biosciences, betting on ventures emerging from the genetic engineering startup's research pipeline.
Sifted's analysis names three priorities for Europe's deeptech spinouts — patient capital, customer obsession and female-founder…
The University of Aberdeen secured three awards at Scotland's Converge innovation and entrepreneurship competition, a result it c…